The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAVV.L Regulatory News (AVV)

  • There is currently no data for AVV

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Completion of Combination

1 Mar 2018 08:00

RNS Number : 3004G
AVEVA Group PLC
01 March 2018
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE AND IN PART, DIRECTLY OR INDIRECTLY IN OR INTO AUSTRALIA, CANADA, JAPAN, THE REPUBLIC OF SOUTH AFRICA, THE UNITED STATES OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION

 

1 March 2018

 

AVEVA GROUP PLC ("AVEVA" or "the Company")

Completion of Combination with Schneider Electric industrial software business

 

AVEVA, a global leader in engineering and industrial software, is pleased to announce that Completion of the Combination with the Schneider Electric industrial software business took place this morning at 8.00 a.m. The combination creates a global leader in engineering and industrial software with an unmatched set of solutions covering all aspects of digital asset management.

 

Defined terms used in this announcement shall have the meaning given to them in the Prospectus published by the Company on 5 September 2017. All references to time are to the time in London, England.

 

Admission of the 97,169,655 Consideration Shares issued to Schneider Electric Group and re-admission of the Company's 64,037,660 existing Ordinary Shares to the premium listing segment of the Official List of the London Stock Exchange occurred this morning at 8.00 a.m. AVEVA's share capital has increased to 161,207,315 ordinary shares and the total number of voting rights is now 161,207,315.

 

As previously announced, the Return of Value will be effected by way of an issue of B Shares. 64,037,660 B Shares of £10.15 each will be issued today on the basis of 1 B Share for each Ordinary Share held at the record date. Each B share will be redeemed today. From seven days following this, there will be a despatch of cheques or, if Ordinary Shares are held in CREST, CREST accounts will be credited in respect of the proceeds of redemption.

 

As previously announced, the record date for the £650 million cash Return of Value to AVEVA shareholders (£10.15 per Ordinary Share) was 6.00 p.m. on 28 February 2018. The ordinary shares of AVEVA are therefore now trading ex the right to receive B shares.

 

The Company is also pleased to announce that, with effect from Completion, Emmanuel Babeau and Peter Herweck have been appointed non-executive directors of the Company. With effect from Completion, Emmanuel Babeau has been appointed to the Company's Remuneration Committee and Peter Herweck has been appointed to the Company's Nomination Committee. There are no disclosures required in respect of these appointments under paragraph 9.6.13 of the Listing Rules of the Financial Conduct Authority save for those made in the Company's previous announcement of 8 September 2017 regarding these appointments (RNS number: 2778Q).

 

As previously announced, the effective date of Craig Hayman's appointment as CEO and a director of the Company was 19 February 2018. On the same date, James Kidd moved from CEO to Deputy CEO and CFO and David Ward became Deputy CFO and Company Secretary (and stepped down from the Company's board of directors). The information required to be disclosed under section 430(2B) of the Companies Act 2006 as a result of David Ward ceasing to be a director of the Company on 19 February 2018 is available on AVEVA's website at www.aveva.com/en/Investors/Corporate_Governance.

 

CEO Craig Hayman, said:

"This combination represents a transformational opportunity for AVEVA to drive growth and advance the digitalisation of the industrial world. I am looking forward to working with all of our stakeholders to deliver this opportunity."

 

Enquiries:

 

AVEVA

Philip Aiken

Craig Hayman

James Kidd

Matt Springett

Tel: +44 (0) 1223 55 6655

 

Lead Financial Adviser to AVEVA

Lazard

Tel: +44 (0) 20 7187 2000

Cyrus Kapadia

Richard Hoyle

Philippe Noël

 

Corporate Broker, Sponsor and Financial Adviser to AVEVA

Numis

Tel: +44 (0) 20 7260 1000

Simon Willis

Jamie Lillywhite

 

Financial PR Adviser to AVEVA

FTI Consulting

Tel: +44 (0) 20 3727 1000

Edward Bridges

 

IMPORTANT NOTICES:

Lazard & Co., Limited, which is authorised and regulated in the UK by the Financial Conduct Authority, is acting as financial adviser to AVEVA and no one else in connection with the Combination and will not be responsible to anyone other than AVEVA for providing the protections afforded to clients of Lazard & Co., Limited nor for providing advice in relation to the Combination or any other matters referred to in this announcement. Neither Lazard & Co., Limited nor any of its affiliates owes or accepts any duty, liability or responsibility whatsoever (whether direct or indirect, whether in contract, in tort, under statute or otherwise) to any person who is not a client of Lazard & Co., Limited in connection with this announcement, the Combination or any statement contained herein.

Numis Securities Limited ("Numis"), which is authorised and regulated in the UK by the Financial Conduct Authority, is acting as corporate broker and sponsor to AVEVA and no one else in connection with the Combination and will not be responsible to anyone other than AVEVA for providing the protections afforded to clients of Numis nor for providing advice in relation to the Combination or any other matters referred to in this announcement. Neither Numis nor any of its affiliates owes or accepts any duty, liability or responsibility whatsoever (whether direct or indirect, whether in contract, in tort, under statute or otherwise) to any person who is not a client of Numis, in connection with this announcement, the Combination or any statement contained herein.

Neither this announcement nor any copy of it may be taken or transmitted directly or indirectly into Australia, Canada, the Republic of South Africa, Japan, the United States or to any persons in any of those jurisdictions, except in compliance with applicable securities laws. Any failure to comply with this restriction may constitute a violation of Australian, Canadian, South African, Japanese, or US securities laws. The distribution of this announcement in other jurisdictions may be restricted by law and persons into whose possession this announcement or other information referred to herein comes should inform themselves about, and observe, any such restrictions.

This announcement does not constitute or form part of any offer, invitation to sell, otherwise dispose of or issue, or any solicitation of any offer to purchase or subscribe for, any shares or other securities nor shall it or any part of it, nor the fact of its distribution form the basis of, or be relied on in connection with, any contract commitment or investment decision.

This announcement has been prepared for the purpose of complying with the applicable law and regulation of the United Kingdom and information disclosed may not be the same as that which would have been disclosed if this announcement had been prepared in accordance with the laws and regulations of jurisdictions outside the United Kingdom.

This announcement does not constitute an offer of securities for sale in the United States or an offer to acquire or exchange securities in the United States. No offer to acquire securities or to exchange securities for other securities has been made, or will be made, directly or indirectly, in or into, or by use of the mails, any means or instrumentality of interstate or foreign commerce or any facilities of a national securities exchange of, the United States or any other country in which such offer may not be made other than (i) in accordance with the tender offer requirements under the US Securities Exchange Act of 1934, as amended, or the securities laws of such other country, as the case may be, or (ii) pursuant to an available exemption from such requirements.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCTPMFTMBATBRP
Date   Source Headline
18th Jan 20233:20 pmRNSForm 8.3 - AVEVA Group plc
18th Jan 20232:27 pmRNSForm 8.3 - AVEVA Group plc
18th Jan 20231:59 pmRNSForm 8.3 - AVEVA GROUP PLC
18th Jan 20231:11 pmEQSForm 8.3 - The Vanguard Group, Inc.: AVEVA Group plc
18th Jan 202312:02 pmRNSForm 8.5 (EPT/NON-RI)-AVEVA Group plc Amend
18th Jan 202311:11 amRNSForm 8.5 (EPT/RI) - Aveva Group Plc
18th Jan 202311:00 amRNSSCHEME OF ARRANGEMENT BECOMES EFFECTIVE
18th Jan 20239:58 amRNSForm 8.5 (EPT/NON-RI)-AVEVA Group plc
18th Jan 20239:52 amRNSForm 8.3 - Aveva Group Plc
18th Jan 20239:52 amRNSForm 8.5 (EPT/RI)-AVEVA Group plc
18th Jan 20239:10 amRNSForm 8.5 (EPT/RI)
18th Jan 20237:30 amRNSSuspension- Aveva Group PLC
17th Jan 20233:20 pmRNSForm 8.3 - AVEVA Group plc
17th Jan 20231:23 pmRNSForm 8.3 - AVEVA GROUP PLC
17th Jan 20231:04 pmRNSForm 8.3 - Aveva Group PLC
17th Jan 202312:28 pmRNSForm 8.3 -AVEVA GROUP PLC
17th Jan 202310:38 amRNSForm 8.5 (EPT/RI) - Aveva Group Plc
17th Jan 202310:33 amRNSISSUE AND ALLOTMENT OF NEW AVEVA SHARES
17th Jan 202310:22 amRNSForm 8.3 - Aveva Group Plc
17th Jan 202310:19 amRNSForm 8.5 (EPT/NON-RI)-AVEVA Group plc
17th Jan 202310:10 amRNSForm 8.5 (EPT/RI)-AVEVA Group plc
16th Jan 20233:28 pmRNSCOURT SANCTION OF SCHEME
16th Jan 20233:20 pmRNSForm 8.3 - AVEVA Group plc
16th Jan 20231:30 pmEQSForm 8.3 - The Vanguard Group, Inc.: AVEVA Group plc
16th Jan 202311:24 amRNSForm 8.5 (EPT/RI) - Aveva Group Plc
16th Jan 202311:17 amRNSForm 8.3 - AVEVA GROUP PLC
16th Jan 202311:14 amRNSForm 8.3 - Aveva Group Plc
16th Jan 202310:12 amRNSForm 8.5 (EPT/NON-RI)-AVEVA Group plc
16th Jan 202310:05 amRNSForm 8.5 (EPT/RI)-AVEVA Group plc
16th Jan 20238:53 amRNSForm 8.5 (EPT/RI)
13th Jan 20236:12 pmRNSAveva Group
13th Jan 20233:20 pmRNSForm 8.3 - AVEVA Group plc
13th Jan 20231:33 pmEQSForm 8.3 - The Vanguard Group, Inc.: AVEVA Group plc
13th Jan 202311:20 amRNSForm 8.3 - AVEVA GROUP PLC
13th Jan 202310:26 amRNSForm 8.5 (EPT/RI) - Aveva Group Plc
13th Jan 202310:18 amRNSForm 8.5 (EPT/NON-RI)-AVEVA Group plc
13th Jan 202310:15 amRNSForm 8.5 (EPT/RI)-AVEVA Group plc
13th Jan 20239:01 amRNSForm 8.5 (EPT/RI)
13th Jan 20237:00 amRNSForm 8.3 - AVEVA GROUP PLC Amend
12th Jan 20233:20 pmRNSForm 8.3 - AVEVA Group plc
12th Jan 20233:06 pmRNSForm 8.3 - AVEVA Group plc
12th Jan 20231:24 pmEQSForm 8.3 - The Vanguard Group, Inc.: AVEVA Group plc
12th Jan 202312:05 pmRNSForm 8.3 - AVEVA GROUP PLC
12th Jan 202311:23 amRNSForm 8.5 (EPT/RI) Aveva Group Plc
12th Jan 202310:28 amBUSForm 8.3 - AVV LN Equity 11-January-23 Decrease in Traded Position Disclosure
12th Jan 202310:23 amRNSForm 8.5 (EPT/NON-RI) - AVEVA Group plc
12th Jan 202310:17 amRNSForm 8.5 (EPT/RI) - AVEVA Group plc
12th Jan 20238:35 amRNSForm 8.5 (EPT/RI)
11th Jan 20236:00 pmRNSAveva Group
11th Jan 20233:20 pmRNSForm 8.3 - AVEVA Group plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.